UK markets closed

4D pharma plc (DDDD.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
34.65+1.55 (+4.68%)
At close: 04:35PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 59.68M
Enterprise value 54.11M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)107.49
Price/book (mrq)2.57
Enterprise value/revenue 103.66
Enterprise value/EBITDA -0.97

Trading information

Stock price history

Beta (5Y monthly) 3.12
52-week change 3-66.36%
S&P500 52-week change 3-7.05%
52-week high 3109.00
52-week low 324.47
50-day moving average 340.68
200-day moving average 354.05

Share statistics

Avg vol (3-month) 33.61M
Avg vol (10-day) 31.47M
Shares outstanding 5180.3M
Implied shares outstanding 6N/A
Float 8136.5M
% held by insiders 125.12%
% held by institutions 131.32%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-5,125.63%

Management effectiveness

Return on assets (ttm)-42.64%
Return on equity (ttm)-89.48%

Income statement

Revenue (ttm)718k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-12.00%
Gross profit (ttm)718k
EBITDA -35.45M
Net income avi to common (ttm)-31.94M
Diluted EPS (ttm)-15.10
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)20.97M
Total cash per share (mrq)0.12
Total debt (mrq)12.8M
Total debt/equity (mrq)39.50
Current ratio (mrq)5.21
Book value per share (mrq)0.18

Cash flow statement

Operating cash flow (ttm)-37.92M
Levered free cash flow (ttm)-28.03M